Clinical Trials Logo

Filter by:
NCT ID: NCT05966324 Completed - Hypertension Clinical Trials

Baxdrostat Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Japanese Population

Start date: July 5, 2022
Phase: Phase 1
Study type: Interventional

The goal of this study is to compare the characteristics of baxdrostat (CIN-107) in terms of baxdrostat levels over time in the blood in healthy Japanese and Caucasian volunteer participants.

NCT ID: NCT05965570 Completed - Healthy Volunteers Clinical Trials

A Study to Investigate Effect of Clarithromycin, a Strong CYP3A4 Inhibitor, on Brensocatib Pharmacokinetics in Healthy Participants

Start date: July 28, 2023
Phase: Phase 1
Study type: Interventional

The primary purpose of this study is to determine the effect of clarithromycin on the single-dose pharmacokinetics (PK) of brensocatib in healthy participants.

NCT ID: NCT05965219 Completed - Healthy Volunteers Clinical Trials

A Trial to Evaluate the Effects of Itraconazole and Carbamazepine on the Pharmacokinetics of Emraclidine and of Emraclidine on the Pharmacokinetics of Metformin in Healthy Adult Participants

Start date: August 15, 2023
Phase: Phase 1
Study type: Interventional

The primary purpose of the study is to evaluate the effect of itraconazole, a strong cytochrome P450 (CYP) 3A4 inhibitor, on the pharmacokinetics (PK) of emraclidine and metabolite CV-0000364 in Part A, the effect of carbamazepine, a strong CYP3A4 inducer, on the PK of emraclidine and metabolite CV-0000364 in Part B, and to evaluate the effect of emraclidine on the PK of metformin in Part C in healthy adult participants.

NCT ID: NCT05964088 Completed - Acute Kidney Injury Clinical Trials

Mortality and Morbidity Associated With New Onset Acute Kidney Injury in Critically Ill COVID-19 Infection Patients

Start date: March 1, 2020
Phase:
Study type: Observational

This study explored the incidence of morbidity and mortality associated with AKI in critically ill adult patients infected with COVID-19. There are two groups for comparison. Group1. patients were directly admitted to the intensive care unit (ICU) from the emergency department (ED) Group 2. patients were initially managed on the medical floor and later transferred to the ICU for worsening respiratory status. The investigating team evaluated the correlation of inflammatory markers and common risk factors such as obesity, diabetes, hypertension and ethnicity to the development of AKI in the target population. The primary outcome is mortality participants will received their regular healthcare in a medical setting

NCT ID: NCT05963932 Completed - Healthy Volunteers Clinical Trials

A Study to Assess the Bioavailability and Effect of Food of BMS-986419 Immediate-release Tablet Formulation in Healthy Adult Participants

Start date: August 8, 2023
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the impact of the BMS-986419 new immediate release (IR) tablet formulation compared to the current enteric (DR) capsule formulation, and to assess the effect of food on the drug levels of the IR tablet formulation in healthy adult participants.

NCT ID: NCT05963724 Completed - Colorectal Cancer Clinical Trials

Real-Time CAD for Colonic Neoplasia: A RCT

CAD
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

This study assesses the sensitivity and added benefits of computer-aided detection compared to standard care (white-light) in detecting colon polyps in patients undergoing colonoscopy.

NCT ID: NCT05963594 Completed - Dietary Supplement Clinical Trials

To Evaluate the Post-Prandial Metabolic Effects of Oligomalt in Adults With T2D and in HAO

LORIS-02
Start date: January 23, 2023
Phase: N/A
Study type: Interventional

The goal of this mechanistic, exploratory study is to compare the effectiveness of Oligomalt to Glucidex 40 after eating in adults with Type 2 Diabetes (T2D) and in otherwise healthy adults with overweight or obesity (HAO).

NCT ID: NCT05963282 Completed - Clinical trials for de Novo Heart Failure

Comparative Effectiveness of Entresto (Sacubitril/Valsartan) Versus ACEi/ARB in de Novo Heart Failure Patients

Start date: November 29, 2021
Phase:
Study type: Observational

This was a non-interventional retrospective cohort study of de novo heart failure with reduced ejection fraction (HFrEF) patients (aged ≥18 years) commencing first-line treatment on either sacubitril/valsartan or commencing or continuing angiotensin-converting enzyme inhibitors (ACEi)/angiotensin receptor blocker (ARB) therapy for HF in the United States (US) using the secondary source of data, Optum Electronic Health Records (EHR).

NCT ID: NCT05963230 Completed - Clinical trials for Ultrasound Recordings

ScanNav Anatomy PNB FDA Data Collection Plan

Start date: July 1, 2023
Phase:
Study type: Observational

To gather additional training and/or validation data (recorded ultrasound scans) for ScanNav Anatomy PNB in the following categories: - Femoral Nerve (Femoral) - Interpectoral (PECS I) and pectoserratus (PECS II) - Transversus abdominis plane (TAP) - Serratus Plane (SP) - Infra-inguinal Facia Iliaca (Infra-inguinal FI) Data will be collected in the form of "scenes" (target block view) and "non-scenes" (areas adjacent to the target block view).

NCT ID: NCT05963009 Completed - Hypertension Clinical Trials

Baxdrostat Bioavailability and Bioequivalence Study

Start date: March 11, 2020
Phase: Phase 1
Study type: Interventional

The goal of this study was to compare the characteristics of a new tablet formulation versus an oral solution of CIN-107 (baxdrostat) in terms of CIN-107 levels over time in the blood and to compare the effect of food on these parameters in healthy volunteer participants who received the CIN-107 tablet under fed versus fasted conditions.